Global Ambulatory Infusion Therapy Services Market Growth (Status and Outlook) 2023-2029

Global Ambulatory Infusion Therapy Services Market Growth (Status and Outlook) 2023-2029

Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health care trends, such as an upsurge in specialty medications that require expert-level administration, a population increasing in age, and steep health care costs, a challenging, but lucrative opportunity for pharmacies and pharmacists alike has begun to emerge.
LPI (LP Information)' newest research report, the “Ambulatory Infusion Therapy Services Industry Forecast” looks at past sales and reviews total world Ambulatory Infusion Therapy Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Ambulatory Infusion Therapy Services sales for 2023 through 2029. With Ambulatory Infusion Therapy Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ambulatory Infusion Therapy Services industry.
This Insight Report provides a comprehensive analysis of the global Ambulatory Infusion Therapy Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ambulatory Infusion Therapy Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ambulatory Infusion Therapy Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ambulatory Infusion Therapy Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ambulatory Infusion Therapy Services.
The global Ambulatory Infusion Therapy Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The leading players mainly are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica, Cleveland Clinic, etc. The market is very fragmented because of numerous hospital outpatient infusion services and clinic services
This report presents a comprehensive overview, market shares, and growth opportunities of Ambulatory Infusion Therapy Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Anticoagulation therapy
Chemotherapy
Anti-infective therapies
Hydration therapy
Immune therapy (Ig)
Specialty Injectables
IV Steroids
Wound Care
General Nursing Services
Segmentation by application
Hospital
Clinic
Home
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland Clinic

Please note: The report will take approximately 2 business days to prepare and deliver.